Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients (Q43889349)
Jump to navigation
Jump to search
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients |
scientific article published in March 2002 |
Statements
1 reference
Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients (English)
1 reference
Karin Karlsson
1 reference
Mats Strömberg
1 reference
Jan Liliemark
1 reference
André Delannoy
1 reference
S A N Johnson
1 reference
Anja Porwit
1 reference
Eva Kimby
1 reference
Gerd Lärfars
1 reference
Ilse Cristiansen
1 reference
Göran Nilsson
1 reference
Fredrik Celsing
1 reference
Gunnel Sundström
1 reference
Mikaela Luthman
1 reference
Ulf Tidefelt
1 reference
Jonas Wallvik
1 reference
Gunnar Juliusson
1 reference
1 March 2002
1 reference
1 reference
116
1 reference
3
1 reference
538-548
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference